• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过核磁共振光谱法检测血清中的肿瘤。对所谓的福塞尔试验的批判性评估]

[Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].

作者信息

Schalk K P, Rüterjans H, Kaltwasser J P, Said l-Hadj H, Staffenberger L

机构信息

Abteilung für Hämatologie, Johann-Wolfgang-Goethe-Universität, Frankfurt.

出版信息

Onkologie. 1989 Aug;12 Suppl 1:5-8. doi: 10.1159/000216676.

DOI:10.1159/000216676
PMID:2685697
Abstract

One year ago a new specific test for the detection of cancer was presented. The authors described a new method to measure the line width of lipoproteins in plasma by NMR-spectroscopy. Their results showed a significant decrease of the line width in plasma of patients with cancer compared to normals. The present study gives the results of a cooperative investigation in our institutes to prove the reliability of the so-called Fossel test. We investigated 100 samples, including 27 healthy persons, 13 pregnant women, 13 patients with non malignant and 47 patients with malignant disease without any tumor treatment. Blood samples were drawn after an overnight fasting and EDTA plasma was stored at -18 degrees C NMR spectroscopy was performed by an AM Spectrometer by using deuteriumoxide and water suppression by a decoupling power of 9 L. The mean line width was found 41.07 +/- 6.08 Hz for healthy and 34.40 +/- 10.80 for patients with non malignant diseases. Patients with cancer and other hematological diseases showed a mean of 35.40 +/- 8.0 Hz. Only in pregnancy a significant decrease of the line width (mean 32.60 +/- 5.7 Hz) was observed. Only small differences between normals, patients with cancer and patients with non malignant disease could be found. The wide range of the line width did not allow any discrimination between malignant and non malignant disease.

摘要

一年前,一种用于检测癌症的新型特异性检测方法问世。作者描述了一种通过核磁共振光谱法测量血浆中脂蛋白谱线宽度的新方法。他们的结果显示,与正常人相比,癌症患者血浆中的谱线宽度显著降低。本研究给出了我们各研究所合作调查的结果,以证明所谓的福塞尔检测的可靠性。我们调查了100个样本,包括27名健康人、13名孕妇、13名非恶性疾病患者和47名未经任何肿瘤治疗的恶性疾病患者。空腹过夜后采集血样,将乙二胺四乙酸血浆储存在-18摄氏度。使用AM光谱仪通过氧化氘进行核磁共振光谱分析,并通过9L的去耦功率抑制水峰。健康人的平均谱线宽度为41.07±6.08Hz,非恶性疾病患者为34.40±10.80Hz。癌症患者和其他血液疾病患者的平均值为35.40±8.0Hz。仅在孕期观察到谱线宽度显著降低(平均值为32.60±5.7Hz)。在正常人、癌症患者和非恶性疾病患者之间仅发现了微小差异。谱线宽度的广泛范围不允许对恶性和非恶性疾病进行任何区分。

相似文献

1
[Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].[通过核磁共振光谱法检测血清中的肿瘤。对所谓的福塞尔试验的批判性评估]
Onkologie. 1989 Aug;12 Suppl 1:5-8. doi: 10.1159/000216676.
2
Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测。血浆的水抑制质子核磁共振波谱分析。
N Engl J Med. 1986 Nov 27;315(22):1369-76. doi: 10.1056/NEJM198611273152201.
3
Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.用于检测恶性肿瘤的质子核磁共振波谱分析评估
Clin Chem. 1988 Mar;34(3):505-11.
4
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.血浆水抑制质子核磁共振波谱法检测恶性肿瘤的效能不足。
N Engl J Med. 1990 Apr 5;322(14):953-8. doi: 10.1056/NEJM199004053221403.
5
Detection of tumours with nuclear magnetic resonance spectroscopy of plasma.利用血浆核磁共振波谱法检测肿瘤
Eur J Cancer Clin Oncol. 1989 Mar;25(3):535-43. doi: 10.1016/0277-5379(89)90267-8.
6
[NMR research on blood plasma for tumor detection--a method for mass screening?].[用于肿瘤检测的血浆核磁共振研究——一种大规模筛查方法?]
Arch Geschwulstforsch. 1989;59(2):129-33.
7
Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测:血浆的水抑制质子核磁共振波谱分析
Magn Reson Med. 1987 Oct;5(4):395-7. doi: 10.1002/mrm.1910050414.
8
[H-NMR spectroscopy of plasma cannot be used for cancer screening].血浆的氢核磁共振光谱法不能用于癌症筛查。
Bull Cancer. 1988;75(8):795-800.
9
Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer.高脂血症作为癌症磁共振血浆检测的生化基础。
NMR Biomed. 1988 Feb;1(1):44-9. doi: 10.1002/nbm.1940010108.
10
Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?血浆脂蛋白的质子核磁共振波谱:癌症疾病免疫功能的标志物?
Anticancer Res. 1994 Sep-Oct;14(5A):1839-51.